SCHEMBL2671015

SCHEMBL2671015

CC(C)CCCCCCCCCCCCCCCOCC(C)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.52
USP2 O75604 1/20 0.42
SPHK1 Q9NYA1 2/20 0.42
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.39
SPHK2 Q9NRA0 1/20 0.37
LMNA P02545 1/20 0.37
LPAR5 Q9H1C0 3/20 0.36
PLA2G2C Q5R387 2/20 0.35
TRPV1 Q8NER1 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
RARB P10826 1/20 0.33
MAPK1 P28482 1/20 0.33
TRPA1 O75762 1/20 0.33
PRKD3 O94806 1/20 0.33
PRKCG P05129 1/20 0.33
PRKCB P05771 1/20 0.33
PRKCA P17252 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31146725 1.00 HSD17B10 (0.52) HSD17B10USP2SPHK1HTTTDP1
SCHEMBL31146693 1.00 HSD17B10 (0.52) HSD17B10USP2SPHK1HTTTDP1
SCHEMBL30535828 1.00 HSD17B10 (0.52) HSD17B10USP2SPHK1HTTTDP1
SCHEMBL10405810 1.00 HSD17B10 (0.52) HSD17B10USP2SPHK1HTTTDP1
SCHEMBL3914789 0.91 HSD17B10 (0.56) HSD17B10USP2SPHK1HTTTDP1
SCHEMBL2176537 0.89 HSD17B10 (0.54) HSD17B10USP2SPHK1HTTTDP1
SCHEMBL15831106 0.89 HSD17B10 (0.64) HSD17B10USP2SPHK1HTTTDP1
SCHEMBL15831107 0.89 HSD17B10 (0.64) HSD17B10USP2SPHK1HTTTDP1
SCHEMBL11219746 0.87 USP2 (0.52) HSD17B10USP2SPHK1HTTTDP1
SCHEMBL7613722 0.86 HSD17B10 (0.56) HSD17B10USP2SPHK1HTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-11061200-A None JP disclosed
JP-6040885-A None JP disclosed
US-9278059-B2 Emulsified cosmetic composition KAO CORPORATION (JP) 2016-03-08 US disclosed
US-20150133550-A1 Emulsified Cosmetic Composition KAO CORPORATION (JP) 2015-05-14 US disclosed
US-20140100276-A1 EMULSIFIED COMPOSITION KAO CORPORATION (JP) 2014-04-10 US disclosed
US-8647649-B2 Emulsified composition KAO CORPORATION (JP) 2014-02-11 US disclosed
US-20120108661-A1 EMULSIFIED COMPOSITION KAO CORPORATION (JP) 2012-05-03 US disclosed
JP-H1161200-A DETERGENT FOR PRINTER MIYOSHI OIL & FAT CO LTD 1999-03-05 JP disclosed
JP-H0640885-A WRINKLE IMPROVER KAO CORP 1994-02-15 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140100276-A1 EMULSIFIED COMPOSITION CERT1, S1PR4, S1PR3 HSD17B10 254/4885USP2 2857/4885SPHK1 15/4885
US-20120108661-A1 EMULSIFIED COMPOSITION CERT1, S1PR4, S1PR3 HSD17B10 254/4885USP2 2857/4885SPHK1 15/4885
US-20150133550-A1 Emulsified Cosmetic Composition SGMS2, SGMS1, DEGS1 HSD17B10 385/4885USP2 3859/4885SPHK1 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.